These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 27198069)

  • 1. Gelsolin amyloid angiopathy causes severe disruption of the arterial wall.
    Koskelainen S; Pihlamaa T; Suominen S; Zhao F; Salo T; Risteli J; Baumann M; Kalimo H; Kiuru-Enari S
    APMIS; 2016 Aug; 124(8):639-48. PubMed ID: 27198069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe elastolysis in hereditary gelsolin (AGel) amyloidosis.
    Koskelainen S; Zhao F; Kalimo H; Baumann M; Kiuru-Enari S
    Amyloid; 2020 Jun; 27(2):81-88. PubMed ID: 31814469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gelsolin-related spinal and cerebral amyloid angiopathy.
    Kiuru S; Salonen O; Haltia M
    Ann Neurol; 1999 Mar; 45(3):305-11. PubMed ID: 10072044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular pathology in hereditary gelsolin amyloidosis.
    Kiuru-Enari S; Somer H; Seppäläinen AM; Notkola IL; Haltia M
    J Neuropathol Exp Neurol; 2002 Jun; 61(6):565-71. PubMed ID: 12071640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary gelsolin amyloidosis.
    Kiuru-Enari S; Haltia M
    Handb Clin Neurol; 2013; 115():659-81. PubMed ID: 23931809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutis laxa in hereditary gelsolin amyloidosis.
    Kiuru-Enari S; Keski-Oja J; Haltia M
    Br J Dermatol; 2005 Feb; 152(2):250-7. PubMed ID: 15727635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing amount of amyloid are associated with the severity of clinical features in hereditary gelsolin (AGel) amyloidosis.
    Pihlamaa T; Suominen S; Kiuru-Enari S; Tanskanen M
    Amyloid; 2016 Dec; 23(4):225-233. PubMed ID: 27879149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid in parenchymal organs in gelsolin (AGel) amyloidosis.
    Schmidt EK; Kiuru-Enari S; Atula S; Tanskanen M
    Amyloid; 2019 Sep; 26(3):118-124. PubMed ID: 31122115
    [No Abstract]   [Full Text] [Related]  

  • 9. Amyloid angiopathy in idiopathic Parkinson's disease. Immunohistochemical and ultrastructural study.
    Bertrand E; Lewandowska E; Stepień T; Szpak GM; Pasennik E; Modzelewska J
    Folia Neuropathol; 2008; 46(4):255-70. PubMed ID: 19169967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of human smooth muscle cells to amyloid angiopathy in AL (light-chain) amyloidosis.
    Vora M; Kevil CG; Herrera GA
    Ultrastruct Pathol; 2017; 41(5):358-368. PubMed ID: 28796568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Finnish gelsolin amyloidosis causes significant disease burden but does not affect survival: FIN-GAR phase II study.
    Schmidt EK; Mustonen T; Kiuru-Enari S; Kivelä TT; Atula S
    Orphanet J Rare Dis; 2020 Jan; 15(1):19. PubMed ID: 31952544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid angiopathy of the human brain: immunohistochemical studies using markers for components of extracellular matrix, smooth muscle actin and endothelial cells.
    Zhang WW; Lempessi H; Olsson Y
    Acta Neuropathol; 1998 Dec; 96(6):558-63. PubMed ID: 9845284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons.
    Van Dorpe J; Smeijers L; Dewachter I; Nuyens D; Spittaels K; Van Den Haute C; Mercken M; Moechars D; Laenen I; Kuiperi C; Bruynseels K; Tesseur I; Loos R; Vanderstichele H; Checler F; Sciot R; Van Leuven F
    Am J Pathol; 2000 Oct; 157(4):1283-98. PubMed ID: 11021833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small cerebral vessel disease in familial amyloid and non-amyloid angiopathies: FAD-PS-1 (P117L) mutation and CADASIL. Immunohistochemical and ultrastructural studies.
    Szpak GM; Lewandowska E; Wierzba-Bobrowicz T; Bertrand E; Pasennik E; Mendel T; Stepień T; Leszczyńska A; Rafałowska J
    Folia Neuropathol; 2007; 45(4):192-204. PubMed ID: 18176893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xerostomia in hereditary gelsolin amyloidosis.
    Juusela P; Tanskanen M; Nieminen A; Kari K; Suominen L; Uitto VJ; Kiuru-Enari S
    Amyloid; 2013 Mar; 20(1):39-44. PubMed ID: 23356404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral amyloid angiopathy.
    Yamada M; Naiki H
    Prog Mol Biol Transl Sci; 2012; 107():41-78. PubMed ID: 22482447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtle neuropsychiatric and neurocognitive changes in hereditary gelsolin amyloidosis (AGel amyloidosis).
    Kantanen M; Kiuru-Enari S; Salonen O; Kaipainen M; Hokkanen L
    PeerJ; 2014; 2():e493. PubMed ID: 25097823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral amyloid angiopathy in the elderly: vessel walls changes and relationship with dementia.
    Zekry D; Duyckaerts C; Belmin J; Geoffre C; Moulias R; Hauw JJ
    Acta Neuropathol; 2003 Oct; 106(4):367-73. PubMed ID: 12898153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy.
    Christie R; Yamada M; Moskowitz M; Hyman B
    Am J Pathol; 2001 Mar; 158(3):1065-71. PubMed ID: 11238054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships in Alzheimer's disease between the extent of Abeta deposition in cerebral blood vessel walls, as cerebral amyloid angiopathy, and the amount of cerebrovascular smooth muscle cells and collagen.
    Tian J; Shi J; Smallman R; Iwatsubo T; Mann DM
    Neuropathol Appl Neurobiol; 2006 Jun; 32(3):332-40. PubMed ID: 16640651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.